Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6931917rdf:typepubmed:Citationlld:pubmed
pubmed-article:6931917lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:6931917lifeskim:mentionsumls-concept:C0341628lld:lifeskim
pubmed-article:6931917lifeskim:mentionsumls-concept:C0015392lld:lifeskim
pubmed-article:6931917lifeskim:mentionsumls-concept:C0026845lld:lifeskim
pubmed-article:6931917lifeskim:mentionsumls-concept:C0026724lld:lifeskim
pubmed-article:6931917lifeskim:mentionsumls-concept:C0001143lld:lifeskim
pubmed-article:6931917lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:6931917pubmed:issue4lld:pubmed
pubmed-article:6931917pubmed:dateCreated1980-11-24lld:pubmed
pubmed-article:6931917pubmed:abstractTextAclacinomycin A, a new anthracycline antitumor antibiotic, was given to rabbits by single instillation or single intracutaneous injection and to guinea pigs by single subcutaneous or intramuscular injection to examine the irritative effect. Slight dilatation of blood vessel and swelling in the conjunctiva and nictitating membrane were observed in the eyes of rabbits given 1% solution. Edema in the bulbar conjunctiva, iris and cornea was histologically noted. Washing of the eyes after drug instillation prevented these damages. Subcutaneous and intracutaneous injections of 1% solution (0.2 ml) gave hyperemia, swelling and necrosis at injection site. Cellular infiltration, fibrosis and necrosis were histologically detected. Intramuscular injection of 1% solution (0.2 ml) also provided induration and swelling at injection site. Histologically cellular infiltration and necrosis were observed. These irritative effects were much slighter in administration of 0.1% solution. No change was observed with 0.01% solution.lld:pubmed
pubmed-article:6931917pubmed:languagejpnlld:pubmed
pubmed-article:6931917pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6931917pubmed:citationSubsetIMlld:pubmed
pubmed-article:6931917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6931917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6931917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6931917pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6931917pubmed:statusMEDLINElld:pubmed
pubmed-article:6931917pubmed:monthAprlld:pubmed
pubmed-article:6931917pubmed:issn0368-2781lld:pubmed
pubmed-article:6931917pubmed:authorpubmed-author:ToneHHlld:pubmed
pubmed-article:6931917pubmed:authorpubmed-author:HoriSSlld:pubmed
pubmed-article:6931917pubmed:authorpubmed-author:HiranoSSlld:pubmed
pubmed-article:6931917pubmed:authorpubmed-author:OhmoriKKlld:pubmed
pubmed-article:6931917pubmed:authorpubmed-author:KiyosakiTTlld:pubmed
pubmed-article:6931917pubmed:issnTypePrintlld:pubmed
pubmed-article:6931917pubmed:volume33lld:pubmed
pubmed-article:6931917pubmed:ownerNLMlld:pubmed
pubmed-article:6931917pubmed:authorsCompleteYlld:pubmed
pubmed-article:6931917pubmed:pagination453-65lld:pubmed
pubmed-article:6931917pubmed:dateRevised2009-11-11lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:meshHeadingpubmed-meshheading:6931917-...lld:pubmed
pubmed-article:6931917pubmed:year1980lld:pubmed
pubmed-article:6931917pubmed:articleTitle[Irritative effect of aclacinomycin A on the eye mucous membrane, skin and muscle (author's transl)].lld:pubmed
pubmed-article:6931917pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6931917pubmed:publicationTypeEnglish Abstractlld:pubmed